Top Markets
Coin of the day
I'rom Group Co., Ltd. I'rom Group Co., Ltd.

I'rom Group Co., Ltd.

2372
Classifica tra le azioni #17923
I'rom Group Co., Ltd. is a Japanese enterprise specializing in several key... I'rom Group Co., Ltd. is a Japanese enterprise specializing in several key areas: pioneering advanced medical treatments, offering site management organization (SMO) services, acting as a contract research organization (CRO), and providing various forms of medical support. The company spearheads the creation of cutting-edge medical technologies, particularly in regenerative medicine and gene therapy, to combat conditions like obstructive arteriosclerosis, retinitis pigmentosa, and HIV/AIDS. Their innovative contributions include the Sendai virus vector and the CytoTune-iPS kit, designed for generating induced pluripotent stem cells. Furthermore, I'rom assists medical institutions with clinical trial execution and delivers extensive support for the development of novel drugs and medical equipment, with a focus on cancer, rare, and intractable diseases. The company also oversees the establishment and operation of clinic malls. Founded in Tokyo in 1997, it was formerly known as I'Rom Holdings Co., Ltd. until its name change in July 2015.
Prezzo delle azioni
$18.20
Ultima sincronizzazione: 2025-05-09
Capitalizzazione di mercato
$220.35M
Variazione (1 giorno)
-5.34%
Variazione (1 anno)
0.00%
Paese
JP
Scambia I'rom Group Co., Ltd. (2372)

Categoria

Ricavi di I'rom Group Co., Ltd. (2372)
Ricavi nel Dec 2024 TTM: $119.61M
Secondo gli ultimi rapporti finanziari di I'rom Group Co., Ltd., i ricavi attuali dell'azienda (TTM) sono pari a $119.61M. Nel 2023, l'azienda ha registrato ricavi di $138.21M un aumento rispetto a i ricavi dell'anno 2022, che erano pari a $128.89M. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per I'rom Group Co., Ltd. da 2005 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
2026 (TTM) $119.61M 2.05%
2024 $117.21M -15.20%
2023 $138.21M 7.24%
2022 $128.89M 10.61%
2021 $116.52M 18.27%
2020 $98.53M 3.39%
2019 $95.30M 17.45%
2018 $81.14M 84.82%
2017 $43.90M 20.07%
2016 $36.56M 6.08%
2015 $34.47M -11.37%
2014 $38.89M -45.34%
2013 $71.14M -46.43%
2012 $132.81M -21.31%
2011 $168.78M 14.16%
2010 $147.85M 0.49%
2009 $147.13M 6.89%
2008 $137.65M 9.43%
2007 $125.78M 16.35%
2006 $108.10M 100.44%
2005 $53.93M 0.00%
Ricavi di aziende simili o concorrenti
Azienda Ricavi Differenza nei ricavi Il paese
$78.01B 65,123.26%
US
- -
DE
$3.89B 3,156.35%
SA
$21.81B 18,136.06%
US
- -
MY